As part of a Covid-19 prevention program, Ayurveda&nbsp;bodies have been set up at state, region and district levels in Kerala&nbsp;by the government. Ayur&nbsp;Raksha&nbsp;clinics have also been established at some of the government&nbsp;hospitals, which would provide preventive medicines and health support required by people. The government has started four different projects to promote 'non-drug therapy' in improving the immunity of the&nbsp;people.&nbsp;

As part of a Covid-19 prevention program, Ayurveda bodies have been set up at state, region and district levels in Kerala by the government. Ayur Raksha clinics have also been established at some of the government hospitals, which would provide preventive medicines and health support required by people. The government has started four different projects to promote 'non-drug therapy' in improving the immunity of the people.

Biotechnology major Biocon on Wednesday said it has received approval from the Drugs Controller General of India (DCGI) for a medical device to treat critical Covid-19 patients. The go-ahead is for an extracorporeal blood purification device called 'CytoSorb' to reduce pro-inflammatory cytokines levels in confirmed Covid-19 patients admitted to the ICU with confirmed or imminent respiratory failure. Studies have shown that Covid-19 patients who develop serious complications experience a 'cytokine storm', also known as Cytokine Release Syndrome, which leads to excessive inflammation, organ failure, and death. The licence granted to Biocon will be effective until control of the Covid-19 outbreak in the country. The device was introduced by Biocon in India in 2013 and since then, many patients undergoing organ transplant and sepsis treatment have benefited from it.

According to a survey by non-profit Plan International UK, 73 per cent said women were facing restricted access to menstrual products through shortages or disrupted supply chains. Speaking to 45 health professionals from 30 countries, the survey warned that sanitary product shortage and price hikes due to the pandemic have led to a rise in&nbsp;period poverty. A separate survey by the same group found that women are resorting to using toilet paper as an alternative due to lack of access to period products.&nbsp;

On the occasion&nbsp;of Menstrual Hygiene Day, UNICEF&nbsp;India Representative Yasmin Ali Haque said that the culture of silence around menstruation&nbsp;has grown even further during the pandemic.&nbsp;The is a major problem&nbsp;for women for&nbsp;economically disadvantaged backgrounds who are finding it tougher&nbsp;to manage their periods safely, hygienically and with dignity. To this end, the UN body launched a&nbsp;week-long campaign #RedDotChallenge&nbsp;to raise awareness, break the silence&nbsp;and change negative norms associated with menstruation. Celebrities including&nbsp;Dia Mirza,&nbsp;Aditi Rao Hydari,&nbsp;Diana Penty&nbsp;showed their support for the campaign.&nbsp;

Following WHO's&nbsp;decision to stop the trial for hydroxychloroquine, the French government&nbsp;has banned using the anti-malaria drug for the treatment of Covid-19 patients. The controversial drug has been proven to be harmful in several&nbsp;studies. The&nbsp;French High Council for Public Health has recommended&nbsp;that the drug not be used for clinical trials, following which the government decided to ban its use altogether.&nbsp;

In a first, a newborn baby born on March 11 at a British hospital will join a cannabis-derived treatment trial. The study aims to find if the medicine could reduce the level of brain injury for babies with neonatal hypoxic-ischemic encephalopathy. The baby was born with an unexpected poor condition had to be transferred to a care unit where he received 72 hours of cooling therapy. Another baby born in April is also a part of the same study. The first babies in the trial will get only a 30th of the usual dose to minimise any side-effects. Other&nbsp;neonatal intensive care units in UK and Europe are also involved in the trial which will take a year to complete.&nbsp;

Over 200 organisations representing at least 40 million health workers from around the world have signed an open letter to the G20 leaders to ensure a 'green recovery' from the Covid-19 pandemic. The letter indicates that 7 million premature deaths are caused globally due to air pollution. They urge leaders to strengthen public health systems and warn that environmental degradation could lead to future diseases. The letter states that better preparation could have reduced the impact of the pandemic. Several nations are considering a green recovery plan and taking steps like remote working and reducing greenhouse gases. Some of the signatories include include the World Medical Association, the International Council of Nurses and the Commonwealth Nurses and Midwives Federation.

According to a new study, published in the&nbsp;British Journal of Sports Medicine, movement-based yoga may help improve mental health amid a crisis like the Covid-19 pandemic.&nbsp;Researchers define it as a form of yoga 'where participants are physically active at least 50% of the time, including a sequence of poses with the focus on holding each asana'.&nbsp;Over 1,000 participants across six countries, including India, were analysed. The results showed that movement-based yoga could help in dealing with&nbsp;&nbsp;bipolar disorder, depression and anxiety. The longer you practise yoga, the more benefits you will receive, said researchers. The results were promising, but more data is needed to confirm the findings.
&nbsp;

After its stand-alone trial of Favipiravir&nbsp;entering phase-3, Mumbai-based Glenmark&nbsp;Pharmaceuticals will now test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir&nbsp;together, as a potential Covid-19 treatment.&nbsp;Called the FAITH trial, the study will enroll 158 hospitalized patients with moderate Covid-19. The firm, which has received the approval from the drug regulator, hopes that the 'antivirals&nbsp;different mechanisms of action could complement and enhance efficacy against the new coronavirus.'

Two drugs that have been proposed as a potential treatment for the new coronavirus, hydroxychloroquine and azithromycin, could be a lethal combination according to a new study. The combination could seriously impact the&nbsp;cardiovascular system as per researchers&nbsp;from Vanderbilt and Stanford University, who carried out an observational, retrospective meta-analysis of a WHO database of over 21 million case reports. The reports are dated November 1967-March 2020 across 130 countries. Reports&nbsp;of potentially lethal acute cardiac proarrhythmogenic effects have been described mainly with azithromycin but also with hydroxychloroquine. And together, the risk was even stronger, according to the report published in the journal&nbsp;Circulation.&nbsp;

A second case of transmission of Covid-19 from mink to humans has been reported in the Netherlands. A Dutch worker has tested positive for the infection. According to reports, the worker most likely caught the infection before it was known that the mink were carrying the virus. The worker did not take precautions like wearing masks or gloves, reports state. The risk of further contagion remains low, says&nbsp;the Dutch agricultural minister. The case follows a reported infection last week on a farm, where the disease was discovered in April among mink that are bred for their valuable fur. Keeping mink for fur is a controversial&nbsp;issue in the Netherlands. As per court orders,&nbsp;mink breeding must cease by 2024.

US biotech company&nbsp;Novavax&nbsp;has begun&nbsp;human trials for a Covid-19 vaccine in Australia. If the trials are successful, it hopes to release the vaccine later this year. In the first phase of the trial, 131 volunteers in Melbourne and Brisbane will test the safety of the vaccine and look for early signs of its effectiveness. Novavax&nbsp;is using a recombinant vaccine, which includes genetic engineering to grow harmless copies of the coronavirus spike protein in giant vats of insect cells in a laboratory.&nbsp;Scientists extracted and purified the protein, and packaged it into virus-sized nanoparticles.

As the&nbsp;Universal Orlando&nbsp;theme park gears up to open on the 5th of June, almost three months after it shut down due to the Covid-19 pandemic, park authorities have warned of an 'inherent risk' of Covid-19 to those who visit. A disclaimer on their website states that while they would be taking all necessary precaution in sync with guidelines suggested by the CDC, they cannot guarantee that visitors will not be exposed to the virus. Some measures that the park will be taking to contain the spread of the virus include temperature checks, limiting capacity and necessary face covers.&nbsp;

Researchers from Bristol University believe that 'human challenge studies of Covid-19 vaccine' could help speed up the process of developing a&nbsp;vaccine as well as its efficacy. A human challenge study involves intentionally infecting volunteers with the virus to test treatment possibilities. Researchers shared that the levels of infection in the community are already low, and there may not be enough people secreting the virus to be in contact with volunteers in vaccine projects. Researchers from&nbsp;Warwick University Medical School added that only very healthy young people aged 25 years will take part in the trial and an effective therapy will be worked on. The World Health Organisation has also shared a set of guidelines for human challenge trials.

For the first time in decades, the US FDA has approved a new birth control gel as a non-hormonal contraceptive alternative to the ones available&nbsp;in the market. 'Phexxi' by Evofem Biosciences Inc. makes the pH levels in the vagina 'inhospitable' for the sperm, and acidic and unfit&nbsp;for fertilisation.&nbsp;The Evofem CEO&nbsp;shared that&nbsp;the product has no hormones and no systemic side effects, reports Bloomberg.&nbsp;During the trials,&nbsp;over 10% women did experience vaginal itching and burning but it decreased with each cycle. In a clinical study of 1,400 women, it was noted that the gel prevented pregnancy 86% of the times overall and 93.3% when it was used correctly. Expected to launch in September, the company also has plans to assess the potential of the gel in prevention of chlamydia and gonorrhea in women, later this year.

A front-runner in the global race, the University of Oxford's much-anticipated Covid-19&nbsp;vaccine trial only has a 50% chance of success. Professor&nbsp;Adrian Hill,&nbsp;co-leading the project, told British newspaper Telegraph that&nbsp;an upcoming trial with 10,000 volunteers threatened to give "no results" as the&nbsp;disease is disappearing rapidly in the UK.&nbsp;"It's a race against the virus disappearing, and against time", he said. The lower the transmission rate, the longer it will take to generate data.&nbsp;Doubts have been cast about the jab earlier after the animal trial on monkeys suggested that it didn't stop them from getting infected. The vaccine is currently in trials on humans to prove it is safe.

According to a new study by infectious disease experts in Singapore,&nbsp;Covid-19 patients may no longer be infectious after 11 days of getting sick even though some may still test positive.&nbsp;A positive test &ldquo;does not equate to infectiousness or viable virus,&rdquo; a joint research paper by Singapore&rsquo;s National Centre for Infectious Diseases and the Academy of Medicine said.&nbsp;The virus &ldquo;could not be isolated or cultured after day 11 of illness," the paper states.&nbsp;The research is based on a study of 73 patients in the city-state.&nbsp;The findings may have implications on the country&rsquo;s patient discharge policy, which is currently based on negative test results rather than infectiousness.&nbsp;
&nbsp;
&nbsp;
&nbsp;

According to a study by researchers at&nbsp;Chicago&rsquo;s Northwestern University, the novel coronavirus&nbsp;appears to attack a woman&rsquo;s placenta during&nbsp;pregnancy.&nbsp;Pathological exams carried out on mothers who had just given birth showed injuries to the organ. Such was the extent of the damage that it might reduce the placenta&rsquo;s ability to deliver oxygen and nutrients to the foetus, the study said. Although the research was conducted on only 16 women, it is the largest investigation carried out yet into the health of the placentas in women who had tested positive for Covid-19. The study, however, concludes that there is unlikely to be any negative implications for the unborn baby.

Soon after US drug maker&nbsp;Moderna&nbsp;reported a successful Phase 1 trial of a&nbsp;Covid-19 vaccine, another vaccine developed in China reported positive results in early trials. Reporting their findings in the Lancet journal, researchers said patients who received a single dose of the vaccine produced certain immune cells within two weeks and immunizing anti-bodies within a 28-day inoculation&nbsp;period. The trial conducted across various labs tested 108 patients between the age of 18 to 60.&nbsp;The vaccine, classified as 'recombinant adenovirus type-5 vectored,' acts as a natural infection and works by teaching the immune system how to fight the virus. Phase 2 trial of the vaccine with 508 volunteers has already been started.&nbsp;

Popularised due to US President Donald Trump's support, anti-malarial drug hydroxychloroquine&nbsp;has been linked to an&nbsp;increased risk of death in hospitalized Covid-19 patients in a new study. The study involving over&nbsp;96,000 people virus patients in hospitals found that&nbsp;those treated with HCQ or the related chloroquine had a higher risk of death and heart rhythm problems than patients who were not given the medicines. Published in the Lancet medical journal, the research found no positive benefit for coronavirus&nbsp;from&nbsp;the infamous drug.&nbsp;

The coronavirus&nbsp;pandemic is hampering immunization processes against diseases like measles, polio and cholera which could leave&nbsp;nearly 80 million children under the age of 1 at risk, according to a new World Health Organisation report. Over half of 129 countries where immunization data were available reported moderate, severe or total suspensions of vaccination services during March and April.&nbsp; Due to pandemic restrictions, 46 campaigns to vaccinate children against polio have been suspended in 38 countries, mostly in Africa. Mass immunization campaigns involving millions of health workers cannot be organised amid social distancing guidelines.&nbsp;

Ayurveda bodies set up in hospitals across Kerala

editorji

follow us

download editorji app

home > health > Ayurveda bodies set up in hospitals across Kerala

replay trump newslist

up NEXT IN 5 SECONDS sports newslist

NaN/0

Ayurveda bodies set up in hospitals across Kerala

Apr 28, 2020 08:51 IST

share this news

explore newslists

International

Lifestyle

Hollywood

Sports

Viral

Tech

National

Showbiz

Travel

Local

Health

May 28, 2020 21:00 IST

May 28, 2020 19:40 IST

May 28, 2020 19:20 IST

May 27, 2020 21:20 IST

May 27, 2020 18:00 IST

May 27, 2020 13:30 IST

May 27, 2020 11:00 IST

May 26, 2020 17:30 IST

May 26, 2020 17:07 IST

May 26, 2020 15:10 IST

May 26, 2020 14:10 IST

May 26, 2020 11:00 IST

May 25, 2020 11:20 IST

May 25, 2020 11:20 IST

May 24, 2020 17:50 IST

May 24, 2020 17:30 IST

May 24, 2020 11:29 IST

May 23, 2020 12:40 IST

May 23, 2020 12:30 IST

May 23, 2020 10:50 IST

follow editorji

download editorji

editorji

About Us

Reach us

Navigate

home
> health
> Ayurveda bodies set up in hospitals across Kerala